SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-020446
Filing Date
2020-09-29
Accepted
2020-09-29 17:24:02
Documents
5
Period of Report
2020-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20200928_8k.htm 8-K 54792
2 EXHIBIT 4.1 ex_205380.htm EX-4.1 240996
3 EXHIBIT 4.4.2 ex_205507.htm EX-4.42 105682
4 EXHIBIT 4.9 ex_205381.htm EX-4.9 103949
5 EXHIBIT 99.1 ex_205382.htm EX-99.1 11601
  Complete submission text file 0001437749-20-020446.txt   518682
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 201209798
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences